Stock DNA
Pharmaceuticals & Biotechnology
USD 2,910 Million (Small Cap)
16.00
NA
0.00%
-79.90
-999,999.00%
0.00
Revenue and Profits:
Net Sales:
539 Million
(Quarterly Results - Dec 2025)
Net Profit:
36 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.67%
0%
11.67%
6 Months
4.23%
0%
4.23%
1 Year
5.08%
0%
5.08%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Concentra Group Holdings Parent, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.70%
EBIT Growth (5y)
66.71%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
19.23%
Pledged Shares
0
Institutional Holding
96.82%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
NA
EV to EBIT
3.57
EV to EBITDA
3.26
EV to Capital Employed
-35.42
EV to Sales
1.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
NA
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 74 Schemes (51.01%)
Foreign Institutions
Held by 92 Foreign Institutions (7.09%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
539.10
572.80
-5.88%
Operating Profit (PBDIT) excl Other Income
91.70
116.60
-21.36%
Interest
31.80
29.40
8.16%
Exceptional Items
3.20
-1.40
328.57%
Consolidate Net Profit
36.20
49.80
-27.31%
Operating Profit Margin (Excl OI)
132.40%
168.80%
-3.64%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -5.88% vs 3.99% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -27.31% vs 7.79% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,163.40
1,900.20
13.85%
Operating Profit (PBDIT) excl Other Income
421.40
371.70
13.37%
Interest
110.30
69.70
58.25%
Exceptional Items
-11.40
0.00
Consolidate Net Profit
172.80
171.90
0.52%
Operating Profit Margin (Excl OI)
159.70%
160.20%
-0.05%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.85% vs 3.38% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 0.52% vs -6.93% in Dec 2024






